Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.
about
Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome.Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.Plasma fibronectin supports hemostasis and regulates thrombosisEffects of clopidogrel on mortality, cardiovascular and bleeding outcomes in patients with chronic kidney disease - data from Taiwan acute coronary syndrome full spectrum registry.Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry.A data-driven approach to optimized medication dosing: a focus on heparinDesigning degradable hydrogels for orthogonal control of cell microenvironments.Bleeding complications of unfractionated heparin.Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtableThe impact of pharmacy monitoring and intervention in patients receiving intravenous heparin.Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR).
P2860
Q30402038-6A9F8413-D94E-459F-AFC2-72A521FA7833Q30438893-AF7A6FCA-8E04-4161-AEE2-D953C8E4E417Q30590791-0C853505-8DC8-4A58-B047-5D9FC0CBE421Q30665648-1C2E2AC0-B373-4A7E-90BB-BC22763A0723Q30815367-B09069DA-4026-43DA-A274-A556D05B33F0Q30840644-84293281-9BA0-475B-8314-D53CBB322334Q37146704-11A0A6BE-4A53-4319-8EE3-B400782FD295Q37792099-C1261C70-DDF4-4D02-909A-D499B572B1E5Q37813151-AD667849-F6A5-4634-A9F2-4D710E00845AQ38784199-4040096A-32C3-433E-9C34-99FCAAC032EAQ53356533-EDA16231-1805-4FF5-87DE-22484A54E8D2
P2860
Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@en
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@nl
type
label
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@en
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@nl
prefLabel
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@en
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@nl
P2093
P50
P1476
Unfractionated heparin dosing ...... tion acute coronary syndromes.
@en
P2093
Anita Y Chen
CRUSADE Investigators
Charles V Pollack
Chiara Melloni
Karen P Alexander
Nancy M Allen LaPointe
W Brian Gibler
P304
P356
10.1016/J.AHJ.2008.03.023
P407
P577
2008-06-02T00:00:00Z